Bernhard J Steinhoff, Pavel Klein, Henrik Klitgaard, Cédric Laloyaux, Brian D Moseley, Kristen Ricchetti-Masterson, Felix Rosenow, Joseph I Sirven, Brien Smith, John M Stern, Manuel Toledo, Patricia A Zipfel, Vicente Villanueva. Epilepsy Behav 2021
Times Cited: 16
Times Cited: 16
Times Cited
Times Co-cited
Similarity
Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel.
Cerine C Hansen, Hanna Ljung, Eylert Brodtkorb, Arne Reimers. Behav Neurol 2018
Cerine C Hansen, Hanna Ljung, Eylert Brodtkorb, Arne Reimers. Behav Neurol 2018
43
Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
Baibing Chen, Hyunmi Choi, Lawrence J Hirsch, Austen Katz, Alexander Legge, Richard Buchsbaum, Kamil Detyniecki. Epilepsy Behav 2017
Baibing Chen, Hyunmi Choi, Lawrence J Hirsch, Austen Katz, Alexander Legge, Richard Buchsbaum, Kamil Detyniecki. Epilepsy Behav 2017
37
BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice.
Vicente Villanueva, Francisco Javier López-González, José Angel Mauri, Juan Rodriguez-Uranga, Marta Olivé-Gadea, Javier Montoya, Jesus Ruiz-Giménez, Jorge Zurita. Acta Neurol Scand 2019
Vicente Villanueva, Francisco Javier López-González, José Angel Mauri, Juan Rodriguez-Uranga, Marta Olivé-Gadea, Javier Montoya, Jesus Ruiz-Giménez, Jorge Zurita. Acta Neurol Scand 2019
31
Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial.
Jacqueline A French, Gregory L Krauss, Robert T Wechsler, Xue-Feng Wang, Bree DiVentura, Christian Brandt, Eugen Trinka, Terence J O'Brien, Antonio Laurenza, Anna Patten,[...]. Neurology 2015
Jacqueline A French, Gregory L Krauss, Robert T Wechsler, Xue-Feng Wang, Bree DiVentura, Christian Brandt, Eugen Trinka, Terence J O'Brien, Antonio Laurenza, Anna Patten,[...]. Neurology 2015
25
Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
Isabel Steinig, Felix von Podewils, Gabriel Möddel, Sebastian Bauer, Karl Martin Klein, Esther Paule, Philipp S Reif, Laurent M Willems, Johann Philipp Zöllner, Rhina Kunz,[...]. Epilepsia 2017
Isabel Steinig, Felix von Podewils, Gabriel Möddel, Sebastian Bauer, Karl Martin Klein, Esther Paule, Philipp S Reif, Laurent M Willems, Johann Philipp Zöllner, Rhina Kunz,[...]. Epilepsia 2017
25
Brivaracetam add-on for refractory focal epilepsy: A systematic review and meta-analysis.
Simona Lattanzi, Claudia Cagnetti, Nicoletta Foschi, Leandro Provinciali, Mauro Silvestrini. Neurology 2016
Simona Lattanzi, Claudia Cagnetti, Nicoletta Foschi, Leandro Provinciali, Mauro Silvestrini. Neurology 2016
25
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
Berkley A Lynch, Nathalie Lambeng, Karl Nocka, Patricia Kensel-Hammes, Sandra M Bajjalieh, Alain Matagne, Bruno Fuks. Proc Natl Acad Sci U S A 2004
Berkley A Lynch, Nathalie Lambeng, Karl Nocka, Patricia Kensel-Hammes, Sandra M Bajjalieh, Alain Matagne, Bruno Fuks. Proc Natl Acad Sci U S A 2004
25
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.
Martin J Brodie, Frank Besag, Alan B Ettinger, Marco Mula, Gabriella Gobbi, Stefano Comai, Albert P Aldenkamp, Bernhard J Steinhoff. Pharmacol Rev 2016
Martin J Brodie, Frank Besag, Alan B Ettinger, Marco Mula, Gabriella Gobbi, Stefano Comai, Albert P Aldenkamp, Bernhard J Steinhoff. Pharmacol Rev 2016
25
Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
Martin Hirsch, Mandy Hintz, Anja Specht, Andreas Schulze-Bonhage. Seizure 2018
Martin Hirsch, Mandy Hintz, Anja Specht, Andreas Schulze-Bonhage. Seizure 2018
25
Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
Martyn D Wood, Michel Gillard. Epilepsia 2017
Martyn D Wood, Michel Gillard. Epilepsia 2017
18
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology.
Robert S Fisher, J Helen Cross, Jacqueline A French, Norimichi Higurashi, Edouard Hirsch, Floor E Jansen, Lieven Lagae, Solomon L Moshé, Jukka Peltola, Eliane Roulet Perez,[...]. Epilepsia 2017
Robert S Fisher, J Helen Cross, Jacqueline A French, Norimichi Higurashi, Edouard Hirsch, Floor E Jansen, Lieven Lagae, Solomon L Moshé, Jukka Peltola, Eliane Roulet Perez,[...]. Epilepsia 2017
18
A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures.
Pavel Klein, Jimmy Schiemann, Michael R Sperling, John Whitesides, Wei Liang, Tracy Stalvey, Christian Brandt, Patrick Kwan. Epilepsia 2015
Pavel Klein, Jimmy Schiemann, Michael R Sperling, John Whitesides, Wei Liang, Tracy Stalvey, Christian Brandt, Patrick Kwan. Epilepsia 2015
18
Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Philippe Ryvlin, Konrad J Werhahn, Barbara Blaszczyk, Martin E Johnson, Sarah Lu. Epilepsia 2014
Philippe Ryvlin, Konrad J Werhahn, Barbara Blaszczyk, Martin E Johnson, Sarah Lu. Epilepsia 2014
18
Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
Michel Gillard, Bruno Fuks, Karine Leclercq, Alain Matagne. Eur J Pharmacol 2011
Michel Gillard, Bruno Fuks, Karine Leclercq, Alain Matagne. Eur J Pharmacol 2011
18
Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany.
Laurent M Willems, Astrid Bertsche, Frank Bösebeck, Frauke Hornemann, Ilka Immisch, Karl M Klein, Susanne Knake, Rhina Kunz, Gerhard Kurlemann, Lisa Langenbruch,[...]. Front Neurol 2018
Laurent M Willems, Astrid Bertsche, Frank Bösebeck, Frauke Hornemann, Ilka Immisch, Karl M Klein, Susanne Knake, Rhina Kunz, Gerhard Kurlemann, Lisa Langenbruch,[...]. Front Neurol 2018
18
Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Victor Biton, Samuel F Berkovic, Bassel Abou-Khalil, Michael R Sperling, Martin E Johnson, Sarah Lu. Epilepsia 2014
Victor Biton, Samuel F Berkovic, Bassel Abou-Khalil, Michael R Sperling, Martin E Johnson, Sarah Lu. Epilepsia 2014
18
Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents.
Susanne Schubert-Bast, Laurent M Willems, Gerhard Kurlemann, Susanne Knake, Karen Müller-Schlüter, Felix Rosenow, Adam Strzelczyk. Epilepsy Behav 2018
Susanne Schubert-Bast, Laurent M Willems, Gerhard Kurlemann, Susanne Knake, Karen Müller-Schlüter, Felix Rosenow, Adam Strzelczyk. Epilepsy Behav 2018
18
Brivaracetam as add-on treatment in focal epilepsy: A real-world time-based analysis.
Simona Lattanzi, Giovanni De Maria, Eleonora Rosati, Giuseppe Didato, Valentina Chiesa, Federica Ranzato, Laura Canafoglia, Edward Cesnik, Francesca Anzellotti, Stefano Meletti,[...]. Epilepsia 2021
Simona Lattanzi, Giovanni De Maria, Eleonora Rosati, Giuseppe Didato, Valentina Chiesa, Federica Ranzato, Laura Canafoglia, Edward Cesnik, Francesca Anzellotti, Stefano Meletti,[...]. Epilepsia 2021
33
Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis.
Christian Brandt, Pavel Klein, Vincent Badalamenti, Teresa Gasalla, John Whitesides. Epilepsy Behav 2020
Christian Brandt, Pavel Klein, Vincent Badalamenti, Teresa Gasalla, John Whitesides. Epilepsy Behav 2020
18
Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy.
Piero Perucca, Jewell Carter, Victoria Vahle, Frank G Gilliam. Neurology 2009
Piero Perucca, Jewell Carter, Victoria Vahle, Frank G Gilliam. Neurology 2009
18
Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304.
Jacqueline A French, Gregory L Krauss, Victor Biton, David Squillacote, Haichen Yang, Antonio Laurenza, Dinesh Kumar, Michael A Rogawski. Neurology 2012
Jacqueline A French, Gregory L Krauss, Victor Biton, David Squillacote, Haichen Yang, Antonio Laurenza, Dinesh Kumar, Michael A Rogawski. Neurology 2012
18
Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.
G L Krauss, J M Serratosa, V Villanueva, M Endziniene, Z Hong, J French, H Yang, D Squillacote, H B Edwards, J Zhu,[...]. Neurology 2012
G L Krauss, J M Serratosa, V Villanueva, M Endziniene, Z Hong, J French, H Yang, D Squillacote, H B Edwards, J Zhu,[...]. Neurology 2012
18
Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
Jacqueline A French, Gregory L Krauss, Bernhard J Steinhoff, David Squillacote, Haichen Yang, Dinesh Kumar, Antonio Laurenza. Epilepsia 2013
Jacqueline A French, Gregory L Krauss, Bernhard J Steinhoff, David Squillacote, Haichen Yang, Dinesh Kumar, Antonio Laurenza. Epilepsia 2013
18
Suicidality Risk of Newer Antiseizure Medications: A Meta-analysis.
Pavel Klein, Orrin Devinsky, Jacqueline French, Cynthia Harden, Gregory L Krauss, Robert McCarter, Michael R Sperling. JAMA Neurol 2021
Pavel Klein, Orrin Devinsky, Jacqueline French, Cynthia Harden, Gregory L Krauss, Robert McCarter, Michael R Sperling. JAMA Neurol 2021
21
Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel.
Alan B Ettinger, Antonia LoPresti, Haichen Yang, Betsy Williams, Sharon Zhou, Randi Fain, Antonio Laurenza. Epilepsia 2015
Alan B Ettinger, Antonia LoPresti, Haichen Yang, Betsy Williams, Sharon Zhou, Randi Fain, Antonio Laurenza. Epilepsia 2015
18
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, Sara Casciato, Valentina Chiesa, Filippo Dainese, Giovanni De Maria, Giuseppe Didato, Giovanni Falcicchio, Martina Fanella,[...]. CNS Drugs 2021
Simona Lattanzi, Laura Canafoglia, Maria Paola Canevini, Sara Casciato, Valentina Chiesa, Filippo Dainese, Giovanni De Maria, Giuseppe Didato, Giovanni Falcicchio, Martina Fanella,[...]. CNS Drugs 2021
21
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.
Wolfgang Löscher, Michel Gillard, Zara A Sands, Rafal M Kaminski, Henrik Klitgaard. CNS Drugs 2016
Wolfgang Löscher, Michel Gillard, Zara A Sands, Rafal M Kaminski, Henrik Klitgaard. CNS Drugs 2016
18
The adverse event profile of levetiracetam: A meta-analysis on children and adults.
Alberto Verrotti, Giovanni Prezioso, Fabiana Di Sabatino, Valentina Franco, Francesco Chiarelli, Gaetano Zaccara. Seizure 2015
Alberto Verrotti, Giovanni Prezioso, Fabiana Di Sabatino, Valentina Franco, Francesco Chiarelli, Gaetano Zaccara. Seizure 2015
18
Brivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities.
Evangelia Theochari, Hannah Cock, Dora Lozsadi, Clare Galtrey, Jan Arevalo, Marco Mula. Epilepsy Behav 2019
Evangelia Theochari, Hannah Cock, Dora Lozsadi, Clare Galtrey, Jan Arevalo, Marco Mula. Epilepsy Behav 2019
18
Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey.
Bernhard J Steinhoff, Matthias Bacher, Iancu Bucurenciu, Barbara Hillenbrand, Tassanai Intravooth, Reinhold Kornmeier, Christoph Kurth, Jakob Stockinger, Anke M Staack. Seizure 2017
Bernhard J Steinhoff, Matthias Bacher, Iancu Bucurenciu, Barbara Hillenbrand, Tassanai Intravooth, Reinhold Kornmeier, Christoph Kurth, Jakob Stockinger, Anke M Staack. Seizure 2017
18
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
Vicente Villanueva, Javier Montoya, Ascension Castillo, José Á Mauri-Llerda, Pau Giner, Francisco J López-González, Anna Piera, Pedro Villanueva-Hernández, Vicente Bertol, Alejandro Garcia-Escrivá,[...]. Epilepsia 2018
Vicente Villanueva, Javier Montoya, Ascension Castillo, José Á Mauri-Llerda, Pau Giner, Francisco J López-González, Anna Piera, Pedro Villanueva-Hernández, Vicente Bertol, Alejandro Garcia-Escrivá,[...]. Epilepsia 2018
12
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.
S F Berkovic, R C Knowlton, R F Leroy, J Schiemann, U Falter. Neurology 2007
S F Berkovic, R C Knowlton, R F Leroy, J Schiemann, U Falter. Neurology 2007
12
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.
Ingrid E Scheffer, Samuel Berkovic, Giuseppe Capovilla, Mary B Connolly, Jacqueline French, Laura Guilhoto, Edouard Hirsch, Satish Jain, Gary W Mathern, Solomon L Moshé,[...]. Epilepsia 2017
Ingrid E Scheffer, Samuel Berkovic, Giuseppe Capovilla, Mary B Connolly, Jacqueline French, Laura Guilhoto, Edouard Hirsch, Satish Jain, Gary W Mathern, Solomon L Moshé,[...]. Epilepsia 2017
12
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.
Zhibin Chen, Martin J Brodie, Danny Liew, Patrick Kwan. JAMA Neurol 2018
Zhibin Chen, Martin J Brodie, Danny Liew, Patrick Kwan. JAMA Neurol 2018
12
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
Terence J O'Brien, Simon Borghs, Qin Jane He, Anne-Liv Schulz, Stephen Yates, Victor Biton. Epilepsia 2020
Terence J O'Brien, Simon Borghs, Qin Jane He, Anne-Liv Schulz, Stephen Yates, Victor Biton. Epilepsia 2020
14
Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus.
Adam Strzelczyk, Lara Kay, Sebastian Bauer, Ilka Immisch, Karl Martin Klein, Susanne Knake, Alexander Kowski, Rhina Kunz, Gerhard Kurlemann, Lisa Langenbruch,[...]. Epilepsia 2018
Adam Strzelczyk, Lara Kay, Sebastian Bauer, Ilka Immisch, Karl Martin Klein, Susanne Knake, Alexander Kowski, Rhina Kunz, Gerhard Kurlemann, Lisa Langenbruch,[...]. Epilepsia 2018
12
Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
Elinor Ben-Menachem, Rūta Mameniškienė, Pier Paolo Quarato, Pavel Klein, Jessica Gamage, Jimmy Schiemann, Martin E Johnson, John Whitesides, Belinda McDonough, Klaus Eckhardt. Neurology 2016
Elinor Ben-Menachem, Rūta Mameniškienė, Pier Paolo Quarato, Pavel Klein, Jessica Gamage, Jimmy Schiemann, Martin E Johnson, John Whitesides, Belinda McDonough, Klaus Eckhardt. Neurology 2016
12
Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
A Matagne, D-G Margineanu, B Kenda, P Michel, H Klitgaard. Br J Pharmacol 2008
A Matagne, D-G Margineanu, B Kenda, P Michel, H Klitgaard. Br J Pharmacol 2008
12
Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Patrick Kwan, Eugen Trinka, Wim Van Paesschen, Ivan Rektor, Martin E Johnson, Sarah Lu. Epilepsia 2014
Patrick Kwan, Eugen Trinka, Wim Van Paesschen, Ivan Rektor, Martin E Johnson, Sarah Lu. Epilepsia 2014
12
Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
Ali A Asadi-Pooya, Michael R Sperling, Steve Chung, Pavel Klein, Anyzeila Diaz, Sami Elmoufti, Jimmy Schiemann, John Whitesides. Epilepsy Res 2017
Ali A Asadi-Pooya, Michael R Sperling, Steve Chung, Pavel Klein, Anyzeila Diaz, Sami Elmoufti, Jimmy Schiemann, John Whitesides. Epilepsy Res 2017
12
Randomized controlled antiepileptic drug trials miss almost all patients with ongoing seizures.
Bernhard J Steinhoff, Anke M Staack, Barbara C Hillenbrand. Epilepsy Behav 2017
Bernhard J Steinhoff, Anke M Staack, Barbara C Hillenbrand. Epilepsy Behav 2017
15
Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.
Manuel Toledo, John Whitesides, Jimmy Schiemann, Martin E Johnson, Klaus Eckhardt, Belinda McDonough, Simon Borghs, Patrick Kwan. Epilepsia 2016
Manuel Toledo, John Whitesides, Jimmy Schiemann, Martin E Johnson, Klaus Eckhardt, Belinda McDonough, Simon Borghs, Patrick Kwan. Epilepsia 2016
12
An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam.
Stephen L Yates, Toufic Fakhoury, Wei Liang, Klaus Eckhardt, Simon Borghs, Joseph D'Souza. Epilepsy Behav 2015
Stephen L Yates, Toufic Fakhoury, Wei Liang, Klaus Eckhardt, Simon Borghs, Joseph D'Souza. Epilepsy Behav 2015
12
Antiepileptic drugs and psychopathology of epilepsy: an update.
Marco Mula, Francesco Monaco. Epileptic Disord 2009
Marco Mula, Francesco Monaco. Epileptic Disord 2009
12
Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggression.
Steve Chung, Betsy Williams, Cindy Dobrinsky, Anna Patten, Haichen Yang, Antonio Laurenza. Epilepsy Behav 2017
Steve Chung, Betsy Williams, Cindy Dobrinsky, Anna Patten, Haichen Yang, Antonio Laurenza. Epilepsy Behav 2017
12
The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy.
Francesco Deleo, Rui Quintas, Katherine Turner, Giuseppe Didato, Elena Zambrelli, Irene Pappalardo, Valentina Chiesa, Chiara Pastori, Marco de Curtis, Maria Paola Canevini,[...]. Epilepsy Behav 2019
Francesco Deleo, Rui Quintas, Katherine Turner, Giuseppe Didato, Elena Zambrelli, Irene Pappalardo, Valentina Chiesa, Chiara Pastori, Marco de Curtis, Maria Paola Canevini,[...]. Epilepsy Behav 2019
22
A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy.
Antonio Gil-Nagel, Sergey Burd, Manuel Toledo, Josemir W Sander, Anna Lebedeva, Anna Patten, Antonio Laurenza. Seizure 2018
Antonio Gil-Nagel, Sergey Burd, Manuel Toledo, Josemir W Sander, Anna Lebedeva, Anna Patten, Antonio Laurenza. Seizure 2018
12
Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy.
Naoya Hasegawa, Jun Tohyama. Epilepsy Behav 2021
Naoya Hasegawa, Jun Tohyama. Epilepsy Behav 2021
40
Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy.
Takahisa Hanada, Yutaka Hashizume, Naoki Tokuhara, Osamu Takenaka, Naohiro Kohmura, Aichi Ogasawara, Shinji Hatakeyama, Makoto Ohgoh, Masataka Ueno, Yukio Nishizawa. Epilepsia 2011
Takahisa Hanada, Yutaka Hashizume, Naoki Tokuhara, Osamu Takenaka, Naohiro Kohmura, Aichi Ogasawara, Shinji Hatakeyama, Makoto Ohgoh, Masataka Ueno, Yukio Nishizawa. Epilepsia 2011
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.